Gregory Laurence, MD
Cosmetic Surgeon, Regenerative Medicine Innovator, and Founder of Germantown Aesthetics & sYlf™ Regenerative Medicine
Gregory Laurence, MD, is a nationally recognized cosmetic surgeon and regenerative medicine specialist based near Memphis, Tennessee. He is the founder of Germantown Aesthetics and sYlf™ Regenerative Medicine, where he integrates cutting-edge biotechnology with advanced surgical techniques to optimize healing, reduce complications, and enhance aesthetic outcomes.
Dr. Laurence is known for pioneering clinical applications of biologics, including autologous cellular technology, exosomes, and regenerative scaffolds - alongside novel protocols that blend surgical precision with redox and micronutrient optimization. His innovations include techniques to prevent capsular contracture, ultra-remote drainage systems, and refinements in neo-umbilicoplasty. His current focus is his sYlf™ boutique longevity practice.
He earned his undergraduate and medical degrees from Baylor University and the University of Texas at Houston, respectively, and completed his residency and GYN fellowship at the University of Tennessee. Beyond clinical care, Dr. Laurence serves as a legal consultant and expert witness in civil, criminal, and licensing matters, and advises healthcare professionals on risk reduction, peer review, and regulatory compliance.
As a keynote speaker and educator, Dr. Laurence has delivered more than 20 unique lectures across six medical specialties, covering topics such as surgical innovation, laser medicine, stromal-derived progenitor cell therapies, facial injectables, and continuous quality improvement. He currently serves as resident healthcare expert and board member of the Financial Policy Council in New York, contributing to future-focused models that integrate regenerative medicine, blockchain, and predictive analytics to transform employer-based healthcare delivery.
At the 2025 C-MPOSIUM, Dr. Laurence will deliver two presentations: one on clinical innovations in regenerative and aesthetic medicine and another on risk mitigation and legal safeguards in surgical and biologic practice.
The Regenerative Edge: Vitamin C in Stem Cell Therapies and Cosmetic Procedurese
From Exosomes to Enhancements—Optimizing Cellular Repair and Surgical Precision in Modern Aesthetic Medicine
Abstract
This session explores the central role of Vitamin C, specifically in its bioactive, pH-neutral form as sodium ascorbate, as a regulatory cofactor in regenerative and aesthetic medicine. Far beyond its antioxidant label, ascorbate actively modulates mesenchymal stem cell viability, extracellular matrix synthesis, collagen stabilization, and angiogenesis, all of which are critical for tissue repair and post-surgical optimization.
Attendees will be introduced to the Regenerative Triad: cells, signaling, and scaffolding - a systems-based model that underpins successful regenerative outcomes. Within this framework, sodium ascorbate facilitates redox homeostasis, enhances growth factor signaling, and stabilizes connective tissue architecture, making it a valuable adjunct in procedures involving fat grafts, stem cells, exosomes, and biologic matrices.
Special focus is placed on how pH neutrality and sodium-coupled transport mechanisms (SVCT1/SVCT2) distinguish sodium ascorbate from unbuffered ascorbic acid, minimizing risks of local acidosis, fibrosis, or tissue incompatibility. These considerations may be critical when used intraoperatively or in graft-supportive environments.
Clinical case reviews illustrate how strategic ascorbate integration improves post-surgical healing, supports stem cell engraftment and exosome signaling, and promotes tissue coherence across musculoskeletal and aesthetic applications.
Learning Objectives
Upon completion of this session, participants will be able to:
- Describe the biologic role of high-dose Vitamin C in regenerative medicine, particularly its effects on stem cell function, extracellular matrix synthesis, and tissue healing.
- Apply the regenerative triad model of cells, signaling, and scaffolding. By integrating Vitamin C and other micronutrients clinician will enhance surgical and aesthetic outcomes.
- Evaluate case studies combining Vitamin C with stem cells, exosomes, and biologic scaffolds, and discuss best practices for safety, ethics, and protocol design.
The Precision, Protocols & Prevention: Mitigating Risk in Regenerative and Surgical Practicee
From Biologics to Blade, From Ascorbate to Arbitration—Strategies for Legal Protection and Patient-Centered Outcomese
Abstract
As regenerative and aesthetic procedures evolve, so too must the clinician’s fluency in ethical practice, regulatory compliance, and protocol-driven innovation. This session addresses the complex interface between clinical advancement and legal oversight in regenerative medicine and cosmetic surgery, providing a practical framework for protecting both patient outcomes and professional licensure.
Participants will examine distinctions between FDA-regulated and non-regulated interventions, including autologous and allogeneic biologics, and the shifting standards governing their use in surgical and non-surgical care. Attention is given to the use of evidence-based adjuncts, such as ascorbate, biologic matrices, and redox modulators, to optimize tissue quality, incision healing, and procedural recovery.
Through case-based exploration, clinicians will identify common compliance pitfalls, including informed consent, therapeutic marketing, and off-label claims, while gaining tools to implement risk-mitigation strategies such as arbitration clauses, internal peer review, and quality improvement systems. Emphasis is placed on aligning innovation with legal prudence to advance safe, ethical, and patient-centered regenerative care.
Learning Objectives
Upon completion of this session, participants will be able to:
- Differentiate between FDA-regulated and non-regulated aspects of regenerative and surgical practice, and understand the ethical implications of innovation.
- Evaluate evidence-based protocols for improving surgical outcomes using ascorbate and biologic materials, including their roles in healing and tissue quality.
- Identify compliance strategies related to informed consent, therapeutic marketing, and evolving regulatory frameworks.
- Apply legal safeguards such as arbitration clauses, peer review, and quality-assurance protocols to reduce risk and improve patient-centered outcomes.
